{"DataElement":{"publicId":"7797426","version":"1","preferredName":"Common Toxicity Criteria for Adverse Events Personality Change Type","preferredDefinition":"A description of the personality change common toxicity criteria adverse event.","longName":"7797421v1.0:7797423v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7797421","version":"1","preferredName":"Common Toxicity Criteria for Adverse Events Personality Change","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event._A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","longName":"2480706v1.0:7797419v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7797419","version":"1","preferredName":"Personality Change","preferredDefinition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","longName":"C78548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personality Change","conceptCode":"C78548","definition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD95203-9E90-6F79-E053-4EBD850AFFC6","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"ONEDATA","dateModified":"2021-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD95203-9EA1-6F79-E053-4EBD850AFFC6","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"BOLTONE","dateModified":"2022-02-16","changeDescription":"EB 2/16/2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7797423","version":"1","preferredName":"Personality Change Type","preferredDefinition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease._Something distinguishable as an identifiable class based on common qualities.","longName":"7797423v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Personality change","valueDescription":"Personality Change","ValueMeaning":{"publicId":"2946059","version":"1","preferredName":"Personality Change","longName":"2946059","preferredDefinition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personality Change","conceptCode":"C78548","definition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D62D-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CDD95FCA-9999-7FE8-E053-4EBD850A2F9A","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"ONEDATA","dateModified":"2021-10-08","deletedIndicator":"No"},{"value":"Flat affect","valueDescription":"Flat Affect","ValueMeaning":{"publicId":"7797425","version":"1","preferredName":"Flat Affect","longName":"7797425","preferredDefinition":"The absence of emotional expressiveness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flat Affect","conceptCode":"C117196","definition":"The absence of emotional expressiveness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD95FCA-99A6-7FE8-E053-4EBD850A2F9A","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"ONEDATA","dateModified":"2021-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CDD95FCA-99BF-7FE8-E053-4EBD850A2F9A","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"ONEDATA","dateModified":"2021-10-08","deletedIndicator":"No"},{"value":"Other personality change","valueDescription":"Hypomimia","ValueMeaning":{"publicId":"7797926","version":"1","preferredName":"Hypomimia","longName":"7797926","preferredDefinition":"Diminished facial expressiveness due to a loss of motor control of the muscles in the face. Hypomimia is a common sign of Parkinson's disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypomimia","conceptCode":"C182455","definition":"Diminished facial expressiveness due to a loss of motor control of the muscles in the face. Hypomimia is a common sign of Parkinson's disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE2EB196-E9C1-1EE7-E053-4EBD850A101D","latestVersionIndicator":"Yes","beginDate":"2021-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-12","modifiedBy":"ONEDATA","dateModified":"2022-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF6B1FE0-31DD-0B79-E053-4EBD850AA603","beginDate":"2021-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-28","modifiedBy":"ONEDATA","dateModified":"2021-10-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7797422","version":"1","preferredName":"Personality Change Type","preferredDefinition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.:Something distinguishable as an identifiable class based on common qualities.","longName":"C78548:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Personality Change","conceptCode":"C78548","definition":"A noticeable change in a person's behavior and thinking. Causes include depression, drug or alcohol abuse, brain injuries, brain tumors, and Alzheimer's disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD95FCA-9972-7FE8-E053-4EBD850A2F9A","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"ONEDATA","dateModified":"2021-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD95FCA-9983-7FE8-E053-4EBD850A2F9A","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"MALUMK","dateModified":"2022-02-14","changeDescription":"Released. 02/14/2022 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CPST_TOX_personality_chg_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the personality chan","type":"Preferred Question Text","description":"What was the personality change common toxicity criteria adverse event?","url":null,"context":"NHLBI"},{"name":"Specify type of personality change(s)","type":"Application Standard Question Text","description":"Specify type of personality change(s)","url":null,"context":"NHLBI"},{"name":"Specify type of personality change(s)","type":"Alternate Question Text","description":"Specify type of personality change(s)","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDD96C45-4B20-3254-E053-4EBD850AF624","latestVersionIndicator":"Yes","beginDate":"2021-10-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-10-08","modifiedBy":"KUMMEROA","dateModified":"2022-06-07","changeDescription":"EB 2/16/2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}